Syngene International

Syngene International Dividend Coverage

The Dividend Coverage Ratio of Syngene International (SYNGENE.NS) as of Oct 31, 2026 is 9.79. In the previous year, Dividend Coverage Ratio was 10.15 — a change of -3.49% (lower).

Dividend Coverage

9.79

YoY

-3.49%

Last updated:

Dividend Coverage Ratio of Syngene International is 2025 9.79 . Dividend Coverage Ratio of Syngene International was 2024 10.15 . It decreases by -3.49% lower compared to the previous year.

The Syngene International Dividend Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend Coverage
Date
Dividend Coverage
Jan 1, 2016
12.17 INR
Jan 1, 2017
14.47 INR
Jan 1, 2018
15.38 INR
Jan 1, 2019
16.69 INR
Jan 1, 2022
19.56 INR
Jan 1, 2023
23.07 INR
Jan 1, 2024
10.15 INR
Jan 1, 2025
9.79 INR
The Syngene International Dividend Coverage history
YEARDividend CoverageYoY
9.79-3.49%
10.15-56.03%
23.07+17.99%
19.56+17.18%
16.69+8.54%
15.38+6.26%
14.47+18.91%
12.17—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Syngene International Stock analysis

What does Syngene International do? Syngene International Ltd. was founded in Bangalore, India in 1993 and specializes in the development and manufacturing of pharmaceuticals, as well as biotechnology services. It is a global contract research organization and part of the Biocon Group, a leading biotech company based in India. Syngene's business model is based on collaborations with global customers in the pharmaceutical, biotech, and agrochemical industries. The company offers a wide range of services including research and development, preclinical development, active pharmaceutical ingredients manufacturing, formulation development, clinical development, and commercial manufacturing. Syngene operates in various divisions, including research and development, formulation development, preclinical services, clinical development, and manufacturing of active pharmaceutical ingredients and formulations. It has multiple locations, including research centers in Hyderabad, Chennai, and Pune, in addition to its headquarters in Bangalore. The company is known for its innovative and socially responsible practices, and has received several awards and recognitions, including the Golden Peacock Award for Corporate Social Responsibility in 2018 and the Best Indian CRO Award at the Global Pharma Excellence Awards in 2019. Syngene aims to establish itself as a global leader in biotech and pharmaceutical discovery and development services, with a focus on customer satisfaction and employee experience. It has become a trusted partner for clients in the pharmaceutical, biotech, and agrochemical industries, offering a wide range of services to support drug and biotech product development. Overall, Syngene International Ltd. is a key player in the contract research and development market, providing comprehensive services to support the development and manufacturing of pharmaceutical and biotechnology products. Syngene International is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Syngene International stock

Dividend Coverage Ratio of Syngene International is 9.79 in 2025.

Dividend Coverage Ratio of Syngene International changed from 10.15 to 9.79, representing a -3.49% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Syngene International since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Syngene International historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Syngene International

All Key Metrics — Syngene International